查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585600

生化试剂市场：按产品类型、最终用户划分 - 全球预测 2025-2030

Biochemical Reagents Market by Product Type (Cell & Tissue Culture Reagents, Chromatography Reagents, Electrophoresis Reagents), End-user (Academics & Research, Contract Research Organizations (CROs), Diagnostic Centers) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年生化试剂市值为158.7亿美元，预计2024年将达到168.5亿美元，复合年增长率为6.48%，到2030年将达到246.4亿美元。

生化试剂是生物科学研究和製造过程中促进化学反应所必需的多种物质。其定义为用于各种化学分析和实验的物质，其范围涵盖製药、生物技术和生命科学，并在诊断、药物开发和基因工程中发挥重要作用。分子生物学和个人化医疗的加速发展强调了对生化试剂的需求，其中准确和高效的生化检测至关重要。这些试剂可应用于 DNA序列测定、细胞培养和层析法等关键过程，最终用途包括製药、实验室、临床诊断和学术。主要成长要素包括对创新药物的需求快速成长、生物製药领域的扩张以及生命科学领域研究支出的增加。此外，慢性病和感染疾病的日益普及增加了对利用生化试剂的更精确诊断解决方案的需求。新的商机在于生物资讯学和蛋白质组学，其中高度特异性试剂的开发可以彻底改变资料的准确性和有效性。抓住这些机会的研究包括试剂製造商和高科技公司之间的策略联盟，以开发先进的研究工具。然而，该市场面临严格的法律规范、先进试剂的高成本以及导致价格战的竞争加剧等限制。此外，技术过时也是一个重大挑战，因为快速进步可以很快地使现有试剂过时。创新应着重于人工智慧和机器学习的整合，以提高试剂的准确性和效用，特别是在合成生物学和个人化医疗领域。市场多元化且竞争激烈，在挑战中利用创新和持续成长需要深入的研究和策略远见。透过专注于可扩展、经济高效和多功能试剂的合成，公司可以在这个不断变化的环境中培养更大的适应性和弹性。

主要市场统计
基准年[2023] 158.7亿美元
预测年份 [2024] 168.5亿美元
预测年份 [2030] 246.4亿美元
复合年增长率（%） 6.48%

市场动态：揭示快速发展的生化试剂市场的关键市场洞察

生化试剂市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 扩大生化试剂在下一代基因定序和聚合酵素链锁反应的应用
    • 世界慢性病的增加
    • 拓展生化试剂在医疗保健和生命科学领域的应用
  • 市场限制因素
    • 开发生化试剂的高成本
  • 市场机会
    • 政府和生物技术公司增加对生化试剂研发活动的承诺和资助
    • 增加干细胞研究以评估药物毒性
  • 市场挑战
    • 生化试剂开发核准严格规定

波特五力：驾驭生化试剂市场的策略工具

波特的五力框架是了解生化试剂市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解生化试剂市场的外部影响

外部宏观环境因素对生化试剂市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解生化试剂市场竞争状况

生化试剂市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵生化试剂市场供应商绩效评估

FPNV定位矩阵是评估生化试剂市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘生化试剂市场的成功之路

生化试剂市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 扩大生化试剂在下一代基因定序和聚合酵素链锁反应的应用
      • 全球慢性病发生率正在上升
      • 拓展生化试剂在医疗保健和生命科学领域的应用
    • 抑制因素
      • 开发生化试剂的高成本
    • 机会
      • 政府和生物技术公司增加对生化试剂研发活动的承诺和资助
      • 扩大干细胞研究以评估药物毒性
    • 任务
      • 生化试剂开发核准严格规定
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章生化试剂市场：依产品类型

  • 细胞/组织培养试剂
  • 层析法试剂
  • 电泳试剂
  • 聚合酵素链锁反应（PCR）试剂组

第七章生化试剂市场：依最终用户分类

  • 学术与研究
  • 合约研究组织（CRO）
  • 诊断中心
  • 医院
  • 製药和生物技术公司

第八章 南北美洲生化试剂市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太生化试剂市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东、非洲生化试剂市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • Alpha Teknova, Inc.
  • AquaPhoenix Scientific, LLC.
  • Becton, Dickinson and Company.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • bioMerieux, Inc.
  • Biotron Diagnostics Inc.
  • Danaher Corporation
  • ERBA Diagnostics Mannheim
  • Euroclone SpA
  • Genelinx International, Inc.
  • LI-COR, Inc., d/b/a LI-COR Biosciences
  • Lonza Group Ltd.
  • Merck KGaA
  • Promega Corporation
  • ProteoChem, Inc.
  • Quality Biological, Inc.
  • Revvity, Inc.
  • Siemens Healthineers AG
  • Sysmex Asia Pacific Pte Ltd.
  • Takara Bio USA, Inc.
  • Thermo Fisher Scientific Inc.
  • Viagen Biotech, Inc.
  • Waters Corporation
Product Code: MRR-521BAA36E9F1

The Biochemical Reagents Market was valued at USD 15.87 billion in 2023, expected to reach USD 16.85 billion in 2024, and is projected to grow at a CAGR of 6.48%, to USD 24.64 billion by 2030.

Biochemical reagents constitute a diverse array of substances essential for facilitating chemical reactions in bioscientific research and manufacturing processes. Defined as substances used in various chemical analyses and experiments, their scope extends across pharmaceuticals, biotechnology, and life sciences, playing a critical role in diagnostics, drug development, and genetic engineering. The necessity of biochemical reagents is underscored by the accelerating advancements in molecular biology and personalized medicine, where accurate and efficient biochemical assays are indispensable. These reagents find application in critical processes such as DNA sequencing, cell culture, and chromatography, with end-use spanning pharmaceuticals, research labs, clinical diagnostics, and academia. Key growth influences encompass the surging demand for innovative drugs, the expansion of biopharmaceutical sectors, and rising research funding in life sciences. Additionally, the increasing prevalence of chronic and infectious diseases drives the demand for more precise diagnostic solutions utilizing biochemical reagents. Emerging opportunities lie in bioinformatics and proteomics, where the development of high-specificity reagents could revolutionize data accuracy and efficacy. Recommendations to seize such opportunities include strategic partnerships between reagent manufacturers and tech companies for advanced research tools development. However, this market faces limitations like stringent regulatory frameworks, high costs of advanced reagents, and heightened competition leading to price wars. Additionally, technological obsolescence poses significant challenges, where rapid advancements can outdate existing reagents quickly. Innovation should focus on the integration of AI and machine learning to enhance reagent precision and utility, particularly within synthetic biology and personalized medicine sectors. The market reveals a diverse yet highly competitive nature, requiring robust research and strategic foresight to leverage innovation and sustain growth amidst challenges. By focusing on the synthesis of scalable, cost-effective, and multifunctional reagents, companies can foster greater adaptability and resilience in this evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 15.87 billion
Estimated Year [2024] USD 16.85 billion
Forecast Year [2030] USD 24.64 billion
CAGR (%) 6.48%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biochemical Reagents Market

The Biochemical Reagents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing adoption of biochemical reagents for next-generation gene sequencing and polymerase chain reaction
    • Rise in the incidences of chronic diseases globally
    • Expanding the application of biochemical reagents in the healthcare and life science sectors
  • Market Restraints
    • High cost associated with the development of biochemical reagents
  • Market Opportunities
    • Increasing initiatives and funding for research and development activities for biochemical reagents by the governments and biotechnological firms
    • Growing stem cell research to assess the toxicity of medications
  • Market Challenges
    • Strict regulations for the approval of the development of biochemical reagents

Porter's Five Forces: A Strategic Tool for Navigating the Biochemical Reagents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biochemical Reagents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biochemical Reagents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biochemical Reagents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biochemical Reagents Market

A detailed market share analysis in the Biochemical Reagents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biochemical Reagents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biochemical Reagents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biochemical Reagents Market

A strategic analysis of the Biochemical Reagents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biochemical Reagents Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Alpha Teknova, Inc., AquaPhoenix Scientific, LLC., Becton, Dickinson and Company., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMerieux, Inc., Biotron Diagnostics Inc., Danaher Corporation, ERBA Diagnostics Mannheim, Euroclone S.p.A., Genelinx International, Inc., LI-COR, Inc., d/b/a LI-COR Biosciences, Lonza Group Ltd., Merck KGaA, Promega Corporation, ProteoChem, Inc., Quality Biological, Inc., Revvity, Inc., Siemens Healthineers AG, Sysmex Asia Pacific Pte Ltd., Takara Bio USA, Inc., Thermo Fisher Scientific Inc., Viagen Biotech, Inc., and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Biochemical Reagents Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Cell & Tissue Culture Reagents, Chromatography Reagents, Electrophoresis Reagents, and Polymerase Chain Reaction (PCR) Reagent Kits.
  • Based on End-user, market is studied across Academics & Research, Contract Research Organizations (CROs), Diagnostic Centers, Hospitals, and Pharma & Biotech Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing adoption of biochemical reagents for next-generation gene sequencing and polymerase chain reaction
      • 5.1.1.2. Rise in the incidences of chronic diseases globally
      • 5.1.1.3. Expanding the application of biochemical reagents in the healthcare and life science sectors
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the development of biochemical reagents
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing initiatives and funding for research and development activities for biochemical reagents by the governments and biotechnological firms
      • 5.1.3.2. Growing stem cell research to assess the toxicity of medications
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulations for the approval of the development of biochemical reagents
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biochemical Reagents Market, by Product Type

  • 6.1. Introduction
  • 6.2. Cell & Tissue Culture Reagents
  • 6.3. Chromatography Reagents
  • 6.4. Electrophoresis Reagents
  • 6.5. Polymerase Chain Reaction (PCR) Reagent Kits

7. Biochemical Reagents Market, by End-user

  • 7.1. Introduction
  • 7.2. Academics & Research
  • 7.3. Contract Research Organizations (CROs)
  • 7.4. Diagnostic Centers
  • 7.5. Hospitals
  • 7.6. Pharma & Biotech Companies

8. Americas Biochemical Reagents Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biochemical Reagents Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biochemical Reagents Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Alpha Teknova, Inc.
  • 3. AquaPhoenix Scientific, LLC.
  • 4. Becton, Dickinson and Company.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. Bio-Techne Corporation
  • 7. bioMerieux, Inc.
  • 8. Biotron Diagnostics Inc.
  • 9. Danaher Corporation
  • 10. ERBA Diagnostics Mannheim
  • 11. Euroclone S.p.A.
  • 12. Genelinx International, Inc.
  • 13. LI-COR, Inc., d/b/a LI-COR Biosciences
  • 14. Lonza Group Ltd.
  • 15. Merck KGaA
  • 16. Promega Corporation
  • 17. ProteoChem, Inc.
  • 18. Quality Biological, Inc.
  • 19. Revvity, Inc.
  • 20. Siemens Healthineers AG
  • 21. Sysmex Asia Pacific Pte Ltd.
  • 22. Takara Bio USA, Inc.
  • 23. Thermo Fisher Scientific Inc.
  • 24. Viagen Biotech, Inc.
  • 25. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. BIOCHEMICAL REAGENTS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOCHEMICAL REAGENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOCHEMICAL REAGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIOCHEMICAL REAGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIOCHEMICAL REAGENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIOCHEMICAL REAGENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOCHEMICAL REAGENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOCHEMICAL REAGENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY CELL & TISSUE CULTURE REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY CHROMATOGRAPHY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY ELECTROPHORESIS REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR) REAGENT KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY ACADEMICS & RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES BIOCHEMICAL REAGENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. BIOCHEMICAL REAGENTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 105. BIOCHEMICAL REAGENTS MARKET, FPNV POSITIONING MATRIX, 2023